Researchers identify specific potential therapeutic targets for aggressive form of pancreatic cancer

Researchers identify specific potential therapeutic targets for aggressive form of pancreatic cancer

Researchers identify specific potential therapeutic targets for aggressive form of pancreatic cancer

A team of researchers led by Mayo Clinic and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has identified specific potential therapeutic targets for the most aggressive and lethal form of pancreatic cancer.